Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 1-A/A Offering statement
- PART II AND III Part II and III
- 11 Exhibit 11
- 13.1 Exhibit 13.1
- 13.2 Exhibit 13.2
- 13.3 Exhibit 13.3
- 13.4 Exhibit 13.4
- 13.5 Exhibit 13.5
- 13.6 Exhibit 13.6
- 13.7 Exhibit 13.7
- 13.8 Exhibit 13.8
- 13.9 Exhibit 13.9
- 13.10 Exhibit 13.10
- 13.11 Exhibit 13.11
- 13.12 Exhibit 13.12
- 13.13 Exhibit 13.13
- 13.14 Exhibit 13.14
Associated filings
- 19 Jan 22 253G2 Offering circular supplement
- 27 Dec 21 253G2 Offering circular supplement
- 1 Jun 21 253G2 Offering circular supplement
- 19 Jan 21 QUALIF Notice of qualification
- 7 Jan 21 1-A/A Offering $30M in Equity
- 23 Dec 20 1-A/A Offering $30M in Equity
-
4 Dec 20 1-A/A Offering $30M in Equity
- 13 Oct 20 1-A/A Offering $30M in Equity
- 30 Sep 20 1-A/A Offering $30M in Equity
- 28 Aug 20 1-A Offering $30M in Equity
MGRM similar filings
Filing view
External links
Exhibit 13.10
Advertisement: Monogram Doug 30 Sec LEARN_BB
Duration: 30 Seconds
CTA Target: thebonebot.com
CTA Tagline: “Learn”
Dr. Douglas Unis, Founder & CMO: I do about 400 maybe 500 joints a year and I’ve seen every possible complication I’ve seen every bad outcome…and you look at the way we do joint replacement surgery, and its pretty much the same way that we’ve been doing it for 40 or 50 years. There are technologies that are maturing that can really change* the way that we do orthopedic surgery.
Narrator: Monogram is the future of orthopaedics. Visit thebonebot.com to learn more. Thats thebonebot.com.
* Testing the waters disclaimer